Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
Top Cited Papers
Open Access
- 25 January 2011
- journal article
- review article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 6 (1) , 11
Abstract
Stroke is the world's second leading cause of mortality, with a high incidence of severe morbidity in surviving victims. There are currently relatively few treatment options available to minimize tissue death following a stroke. As such, there is a pressing need to explore, at a molecular, cellular, tissue, and whole body level, the mechanisms leading to damage and death of CNS tissue following an ischemic brain event. This review explores the etiology and pathogenesis of ischemic stroke, and provides a general model of such. The pathophysiology of cerebral ischemic injury is explained, and experimental animal models of global and focal ischemic stroke, andin vitrocellular stroke models, are described in detail along with experimental strategies to analyze the injuries. In particular, the technical aspects of these stroke models are assessed and critically evaluated, along with detailed descriptions of the current best-practice murine models of ischemic stroke. Finally, we review preclinical studies using different strategies in experimental models, followed by an evaluation of results of recent, and failed attempts of neuroprotection in human clinical trials. We also explore new and emerging approaches for the prevention and treatment of stroke. In this regard, we note that single-target drug therapies for stroke therapy, have thus far universally failed in clinical trials. The need to investigate new targets for stroke treatments, which have pleiotropic therapeutic effects in the brain, is explored as an alternate strategy, and some such possible targets are elaborated. Developing therapeutic treatments for ischemic stroke is an intrinsically difficult endeavour. The heterogeneity of the causes, the anatomical complexity of the brain, and the practicalities of the victim receiving both timely and effective treatment, conspire against developing effective drug therapies. This should in no way be a disincentive to research, but instead, a clarion call to intensify efforts to ameliorate suffering and death from this common health catastrophe. This review aims to summarize both the present experimental and clinical state-of-the art, and to guide future research directions.Keywords
This publication has 169 references indexed in Scilit:
- Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in miceBrain Research, 2010
- Age and energy intake interact to modify cell stress pathways and stroke outcomeAnnals of Neurology, 2010
- Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disordersExperimental Gerontology, 2009
- Leukocyte Recruitment and Ischemic Brain InjuryNeuroMolecular Medicine, 2009
- Neutrophil elastase and neurovascular injury following focal stroke and reperfusionNeurobiology of Disease, 2009
- Culturing thick brain slices: An interstitial 3D microperfusion system for enhanced viabilityJournal of Neuroscience Methods, 2009
- Toll-like receptors in neurodegenerationBrain Research Reviews, 2009
- Neuroprotection in stroke by complement inhibition and immunoglobulin therapyNeuroscience, 2009
- Neuroprotective strategies targeting apoptotic and necrotic cell death for strokeApoptosis, 2009
- The inflammatory response in strokeJournal of Neuroimmunology, 2007